Applications

Researchers wanting to submit an application for data and/or samples from the Lifelines biobank must follow a five step process. This process is explained here.

Applications

Exploring trauma and pathways of resilience in youth with chronic illness: A developmental perspective
primary applicant:
Nearchou, N.
institute:
UCD (IRL) - School of Psychology
year of approval:
2024
Investigating the gut microbiota characteristics in a global comparison between individuals with irritable bowel syndrome and healthy subjects
primary applicant:
Yuzhu, C.
institute:
Peking University
year of approval:
2024
Real-World Assessments of Repurposed Drugs and COVID-19 Vaccination for Prevention and Treatment of COVID-19: A PharmLines Initiative Study
primary applicant:
Hak, E.
institute:
RuG - Groningen Research Institute of Pharmacy (GRIP)
year of approval:
2024
Uncovering the role of dietary and environmental biodiversity and healthy ageing
primary applicant:
Gallo, V.
institute:
RuG - Campus Fryslân
year of approval:
2024
The relationship between cardiovascular risk factors and renal cell carcinoma: before and after treatment
primary applicant:
Peutz-Kootstra, C.
institute:
PALGA - Pathologisch-Anatomisch Landelijk Geautomatiseerd Archief
year of approval:
2023
Probing interactions between host genetic predisposition, food intake, and the gut microbiome
primary applicant:
Wang, D.
institute:
Harvard Medical School - Brigham and Woman's Hospital
year of approval:
2023
Ondervoeding en overgewicht/obesitas (ZonMW) -Malnutrition and overweight/obesity (SCOOP)
primary applicant:
de van der Schueren, M.
institute:
WUR - Division of Human Nutrition
year of approval:
2023
Constructing risk prediction models of non-communicable diseases based on multiple risk factors
primary applicant:
Cao, Y.
institute:
School of medicine, Shanghai Jiao Tong University (CHN)
year of approval:
2023
Technological validation of error-corrected sequencing of CHIP genes
primary applicant:
Dubé, M.P.
institute:
Montreal Heart Institute
year of approval:
2023
Global metagenomic and metabolomic signatures of diseases that are associated with gut microbiota dysbiosis
primary applicant:
Fan, D.
institute:
Guangdong Medical University (CHN)
year of approval:
2023